{"id":"enoxaparin","rwe":[],"tags":[],"safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[{"effect":"Bleeding","drugRate":"","severity":"common","organSystem":""},{"effect":"Anemia","drugRate":"","severity":"common","organSystem":""},{"effect":"Thrombocytopenia","drugRate":"","severity":"common","organSystem":""},{"effect":"Elevation of serum aminotransferase","drugRate":"","severity":"common","organSystem":""},{"effect":"Diarrhea","drugRate":"","severity":"common","organSystem":""},{"effect":"Nausea","drugRate":"","severity":"common","organSystem":""},{"effect":"Ecchymosis","drugRate":"","severity":"common","organSystem":""},{"effect":"Fever","drugRate":"","severity":"common","organSystem":""},{"effect":"Edema","drugRate":"","severity":"common","organSystem":""},{"effect":"Peripheral edema","drugRate":"","severity":"common","organSystem":""},{"effect":"Dyspnea","drugRate":"","severity":"common","organSystem":""},{"effect":"Confusion","drugRate":"","severity":"common","organSystem":""},{"effect":"Injection site pain","drugRate":"","severity":"common","organSystem":""},{"effect":"Injection site hematomas","drugRate":"9%","severity":"common","organSystem":""}],"contraindications":[],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[{"effect":"Major bleeding - Abdominal Surgery","drugRate":"4%","severity":"serious"},{"effect":"Major bleeding - Colorectal Surgery","drugRate":"4%","severity":"serious"},{"effect":"Major bleeding - Hip Replacement Surgery","drugRate":"4%","severity":"serious"},{"effect":"Hemorrhage","drugRate":"","severity":"serious"}]},"trials":[],"_chembl":{"chemblId":"CHEMBL1201476","moleculeType":"Oligosaccharide"},"aliases":["Lovenox","Inhixa®","Clexan","Clexane","Enoxaparin sodium"],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"_dailymed":{"setId":"45a66675-b159-42b8-9f18-ff80f28e1503","title":"ENOXAPARIN SODIUM INJECTION [CARDINAL HEALTH 107, LLC]"},"ecosystem":[],"mechanism":{"target":"Antithrombin-III"},"_scrapedAt":"2026-03-28T00:42:18.441Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"indications":{"approved":[{"name":"Deep venous thrombosis","diseaseId":"deep-venous-thrombosis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Myocardial infarction","diseaseId":"myocardial-infarction","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Prevention of clot formation during haemodialysis","diseaseId":"prevention-of-clot-formation-during-haemodialysis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Prevention of venous thromboembolism","diseaseId":"prevention-of-venous-thromboembolism","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Pulmonary embolism","diseaseId":"pulmonary-embolism","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Unstable angina","diseaseId":"unstable-angina","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT07499037","phase":"PHASE2","title":"Safety and Efficacy of Low-dose Anticoagulation With Argatroban and Enoxaparin on ECMO","status":"NOT_YET_RECRUITING","sponsor":"University Hospital Ostrava","startDate":"2027-01","conditions":"Pneumonia, Heart Failure","enrollment":200},{"nctId":"NCT05672550","phase":"PHASE4","title":"Dose-adjustment of Enoxaparin by a Bayesian Pharmacological Approach in Pediatric Kidney Transplant Recipients (OPTI-TREX)","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-06-28","conditions":"Pediatric Kidney Transplant Recipients","enrollment":50},{"nctId":"NCT07464808","phase":"NA","title":"Utilizing Anti-Factor Xa as a Predictive Tool for Optimizing Outcome in Burn Patients' Management","status":"RECRUITING","sponsor":"Ain Shams University","startDate":"2025-11-28","conditions":"Venous Thromboembolic Event","enrollment":25},{"nctId":"NCT06825416","phase":"PHASE3","title":"A Clinical Study of SHR-2004 Injection in Preventing Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty","status":"ACTIVE_NOT_RECRUITING","sponsor":"Beijing Suncadia Pharmaceuticals Co., Ltd","startDate":"2025-03-16","conditions":"Prevention of Arterial and Venous Thrombosis","enrollment":1166},{"nctId":"NCT07462182","phase":"NA","title":"Impact of Enoxaparin Therapy on Fetal Outcomes in Intrauterine Growth Restriction","status":"NOT_YET_RECRUITING","sponsor":"Muhammad Aamir Latif","startDate":"2026-04-01","conditions":"Intrauterine Growth Restriction","enrollment":108},{"nctId":"NCT07015905","phase":"PHASE3","title":"REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults","status":"RECRUITING","sponsor":"Regeneron Pharmaceuticals","startDate":"2025-06-25","conditions":"Venous Thromboembolism (VTE)","enrollment":2000},{"nctId":"NCT06454630","phase":"PHASE2","title":"A Trial to Learn How Well REGN7508 Works for Preventing Blood Clots After a Knee Replacement in Adult Participants","status":"COMPLETED","sponsor":"Regeneron Pharmaceuticals","startDate":"2024-06-27","conditions":"Venous Thromboembolism","enrollment":179},{"nctId":"NCT07437716","phase":"NA","title":"Impact Of Laparoscopic Sleeve Gastrectomy On Obesity-Related Comorbidities In Patients Over 65 Years","status":"COMPLETED","sponsor":"Kafrelsheikh University","startDate":"2023-01-01","conditions":"Laparascopic Sleeve Gastrectomy, Obesity & Overweight, Obesity Type 2 Diabetes Mellitus","enrollment":60},{"nctId":"NCT07312851","phase":"PHASE1","title":"A Study to Investigate Andexanet Dosing and the Interaction Between Andexanet and Subsequent Enoxaparin in Healthy Participants","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2026-01-19","conditions":"Healthy Participants","enrollment":186},{"nctId":"NCT07140211","phase":"PHASE3","title":"Short-term Low-dose Low-molecular-weight Heparin to Prevent Postpartum Thrombosis","status":"RECRUITING","sponsor":"Marc Blondon","startDate":"2025-10-15","conditions":"Venous Thromboembolism (VTE), Postpartum","enrollment":9200},{"nctId":"NCT07384598","phase":"NA","title":"Pharmacokinetic Profiles of Subcutaneous Enoxaparin for Thromboprophylaxis in Critically Ill Patients With Renal Failure Treated or Not With Continuous Veno-veinous Hemofiltration.","status":"NOT_YET_RECRUITING","sponsor":"Clinique Saint Pierre Ottignies","startDate":"2026-02-01","conditions":"Thromboprophylaxis, Critical Illness, Intensive Care (ICU)","enrollment":60},{"nctId":"NCT05848713","phase":"PHASE3","title":"AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia","status":"RECRUITING","sponsor":"University of Manitoba","startDate":"2023-10-10","conditions":"Community-acquired Pneumonia","enrollment":4000},{"nctId":"NCT06243510","phase":"NA","title":"Comparison of Apixaban Versus Enoxaparin","status":"ENROLLING_BY_INVITATION","sponsor":"Abramson Cancer Center at Penn Medicine","startDate":"2023-11-24","conditions":"Bladder Cancer","enrollment":90},{"nctId":"NCT04273607","phase":"PHASE2, PHASE3","title":"Anticoagulation-free VV ECMO for Acute Respiratory Failure","status":"RECRUITING","sponsor":"Damian Ratano","startDate":"2022-09-01","conditions":"Extracorporeal Membrane Oxygenation Complication","enrollment":40},{"nctId":"NCT07124819","phase":"PHASE3","title":"Dimolegin® (60 mg) Given Once Daily in Patients Undergoing Total Hip or Knee Replacement Compared to Enoxaparin","status":"COMPLETED","sponsor":"Avexima Diol LLC","startDate":"2024-07-22","conditions":"Arthroplasty, Replacement, Hip, Arthroplasty, Replacement, Knee, Venous Thromboembolism (VTE)","enrollment":215},{"nctId":"NCT07140523","phase":"PHASE2","title":"A Study to Compare the Efficacy and Safety of SRSD107 and Enoxaparin in Adult Subjects Undergoing TKA","status":"RECRUITING","sponsor":"Sirius Therapeutics Co., Ltd.","startDate":"2025-09-16","conditions":"Venous Thromboembolism","enrollment":450},{"nctId":"NCT07330661","phase":"NA","title":"Nursing-Led Deep Vein Thrombosis Prevention in Neurosurgery","status":"COMPLETED","sponsor":"West China Hospital","startDate":"2021-01-01","conditions":"Deep Vein Thrombosis (DVT)","enrollment":1286},{"nctId":"NCT06370273","phase":"PHASE3","title":"Thromboprophylaxis in Lower Limb Immobilisation","status":"RECRUITING","sponsor":"Queen Mary University of London","startDate":"2024-11-12","conditions":"Thrombosis, Injury Leg","enrollment":10044},{"nctId":"NCT07270263","phase":"NA","title":"Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic Malignancies","status":"RECRUITING","sponsor":"Medical University of Gdansk","startDate":"2024-11-22","conditions":"Lymphoma, Leukemia, Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma","enrollment":100},{"nctId":"NCT05255003","phase":"PHASE4","title":"STrategies for Anticoagulation in Patients With thRombocytopenia and Cancer-associated Thrombosis","status":"RECRUITING","sponsor":"Tzu-Fei Wang","startDate":"2022-08-29","conditions":"Cancer-associated Thrombosis, Thrombocytopenia","enrollment":50},{"nctId":"NCT07243080","phase":"PHASE4","title":"Comparative Efficacy of Rivaroxaban and Enoxaparin in Post-Laparotomy DVT Prevention","status":"RECRUITING","sponsor":"Mayo Hospital Lahore","startDate":"2025-10-10","conditions":"Deep Venous Thromboses, Laparotomy Patients","enrollment":212},{"nctId":"NCT01588171","phase":"NA","title":"Comparison of 2 Low Molecular Weight Heparin as a Thromboprophylaxis Postpartum","status":"COMPLETED","sponsor":"Hawler Medical University","startDate":"2012-05","conditions":"Venous Thromboembolic Diseases","enrollment":7020},{"nctId":"NCT05203705","phase":"PHASE2","title":"Clinical Study on the Efficacy and Safety of Multiple Oral Administrations of SHR2285 Tablets in Patients Undergoing Elective Total Knee Arthroplasty","status":"TERMINATED","sponsor":"Shanghai Hengrui Pharmaceutical Co., Ltd.","startDate":"2022-03-07","conditions":"Prevention of Venous Thrombosis After TKA","enrollment":64},{"nctId":"NCT07228663","phase":"PHASE3","title":"Hip Fracture Surgery Arterial and Venous Thrombotic Events Prevention","status":"NOT_YET_RECRUITING","sponsor":"McMaster University","startDate":"2025-12-01","conditions":"Hip Fracture Surgery, Cardiovascular Prevention, Venous Thromboembolism (VTE)","enrollment":100},{"nctId":"NCT04861103","phase":"PHASE4","title":"Anticoagulation Profile in Pregnant Women Treated With Three Times a Day of Low Molecular Weight Heparin (LMWH)","status":"RECRUITING","sponsor":"University of California, Irvine","startDate":"2020-10-01","conditions":"Pregnancy, High Risk, Anticoagulants","enrollment":12},{"nctId":"NCT07213713","phase":"","title":"Evaluation of Anti-Xa Activity in Patients With Severe Obesity After Subcutaneous Injection of Enoxaparin for Antithrombotic Prophylaxis at Two Different Sites.","status":"NOT_YET_RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2025-10-01","conditions":"Venous Thromboembolism, Obese Patients","enrollment":80},{"nctId":"NCT07189897","phase":"PHASE4","title":"Apixaban or Enoxaparin After Head and Neck Cancer Surgery","status":"RECRUITING","sponsor":"Kiranya Arnold","startDate":"2025-10","conditions":"Venous Thromboembolism, Head and Neck Cancer","enrollment":76},{"nctId":"NCT03244020","phase":"PHASE4","title":"LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology","status":"ENROLLING_BY_INVITATION","sponsor":"Massachusetts General Hospital","startDate":"2018-02-16","conditions":"Sarcoma, Soft Tissue Sarcoma, Bone Sarcoma","enrollment":2868},{"nctId":"NCT06357403","phase":"","title":"Association of Anti-factor Xa Activity With Venous Thromboembolism in Critically Ill Patients","status":"RECRUITING","sponsor":"Medical University of Vienna","startDate":"2024-05-04","conditions":"Thrombosis, Pulmonary Embolism, Enoxaparin","enrollment":1300},{"nctId":"NCT06180889","phase":"PHASE2","title":"Factor XI inhibiTion for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty","status":"ACTIVE_NOT_RECRUITING","sponsor":"Suzhou Alphamab Co., Ltd.","startDate":"2023-12-20","conditions":"Knee Arthroplasty, Total","enrollment":241},{"nctId":"NCT07168005","phase":"NA","title":"Informative Video Before LMWH Postpartum - Randomized Controlled Trial","status":"NOT_YET_RECRUITING","sponsor":"Wolfson Medical Center","startDate":"2025-10-15","conditions":"Venous Thromboembolism (VTE), Postpartum Care, Anxiety","enrollment":160},{"nctId":"NCT07165587","phase":"","title":"Incidence of Venous Thromboembolism in Patients With Pelvic and Acetabular Fractures (PAF)","status":"COMPLETED","sponsor":"Department of Trauma and Reconstructive Surgery at Eberhard Karls University Tuebingen, BG Klinik Tu","startDate":"2024-01-01","conditions":"Pelvic Fractures, Acetabular Fractures, Pelvic Trauma","enrollment":81},{"nctId":"NCT06517563","phase":"PHASE1","title":"Effects of VMX-C001 on the Anticoagulant Effect of Different Forms of Heparin","status":"ACTIVE_NOT_RECRUITING","sponsor":"VarmX B.V.","startDate":"2024-08-14","conditions":"Coagulation Disorder","enrollment":16},{"nctId":"NCT06118957","phase":"PHASE2","title":"Low Molecular Weight Heparin or no Treatment Following Cesarean Delivery","status":"COMPLETED","sponsor":"University of Utah","startDate":"2023-10-11","conditions":"Thromboembolism","enrollment":64},{"nctId":"NCT05618808","phase":"PHASE2","title":"A Trial to Learn How Well REGN9933 Works for Preventing Blood Clots After Knee Replacement Surgery in Adult Participants","status":"COMPLETED","sponsor":"Regeneron Pharmaceuticals","startDate":"2023-05-24","conditions":"Venous Thromboembolism","enrollment":373},{"nctId":"NCT06913595","phase":"PHASE1","title":"Low Molecular Weight Heparin vs Direct Oral Anticoagulant After Bariatric Surgery","status":"ACTIVE_NOT_RECRUITING","sponsor":"Cairo University","startDate":"2024-03-25","conditions":"Deep Venous Thrombosis","enrollment":100},{"nctId":"NCT07132515","phase":"PHASE4","title":"Efficacy & Safety of Anticoagulants in Cirrhosis ± HCC","status":"RECRUITING","sponsor":"Mansoura University","startDate":"2023-08-15","conditions":"Cirrhosis, HCC - Hepatocellular Carcinoma, Portal Vein Thrombosis","enrollment":100},{"nctId":"NCT04762992","phase":"PHASE3","title":"LMWH for Treatment of Early Fetal Growth Restriction (HepaGrowth)","status":"ENROLLING_BY_INVITATION","sponsor":"Centro Hospitalar de Lisboa Central","startDate":"2022-07-18","conditions":"Fetal Growth Retardation, Prematurity, Pre-Eclampsia","enrollment":12},{"nctId":"NCT07116239","phase":"NA","title":"Edoxaban Steady-State PK/PD in Adults With Nephrotic Syndrome","status":"NOT_YET_RECRUITING","sponsor":"Peking University People's Hospital","startDate":"2025-09","conditions":"Nephrotic Syndrome, Hypoalbuminemia","enrollment":60},{"nctId":"NCT06094699","phase":"NA","title":"Improving Sleep in the Neurology In-Patient Population","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2023-04-30","conditions":"Sleep","enrollment":145},{"nctId":"NCT06004674","phase":"PHASE2","title":"Using Placental Pathology to Prevent Recurrent Adverse Pregnancy Outcomes: A Pilot Project","status":"RECRUITING","sponsor":"Endeavor Health","startDate":"2023-12-26","conditions":"Adverse Pregnancy Outcome","enrollment":20},{"nctId":"NCT05226793","phase":"","title":"Medication Use Evaluation for Enoxaparin in Hospitalized COVID-19 Patients","status":"COMPLETED","sponsor":"Methodist Health System","startDate":"2021-11-17","conditions":"Venous Thromboembolism","enrollment":400},{"nctId":"NCT06220123","phase":"PHASE2","title":"A Study to Evaluate the Efficacy and Safety of SHR-2004 Injection in Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery","status":"COMPLETED","sponsor":"Beijing Suncadia Pharmaceuticals Co., Ltd","startDate":"2024-02-16","conditions":"Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery","enrollment":225},{"nctId":"NCT06515730","phase":"PHASE4","title":"Treatment With Apixaban Versus Warfarin in Patients With Left Ventricular Thrombus After Acute Myocardial Infarction","status":"RECRUITING","sponsor":"Karolinska Institutet","startDate":"2025-04-08","conditions":"Left Ventricular Thrombus, Acute Myocardial Infarction","enrollment":212},{"nctId":"NCT04504318","phase":"PHASE1, PHASE2","title":"Apixaban vs Enoxaparin Following Microsurgical Breast Reconstruction-An RCT","status":"COMPLETED","sponsor":"Stanford University","startDate":"2020-08-12","conditions":"Venous Thromboembolism","enrollment":82},{"nctId":"NCT04997265","phase":"NA","title":"Strategies for Anticoagulation During Venovenous ECMO","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"2022-05-12","conditions":"Acute Hypoxemic Respiratory Failure, Anticoagulant-induced Bleeding, Thromboembolism","enrollment":26},{"nctId":"NCT04924322","phase":"PHASE2, PHASE3","title":"Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies","status":"RECRUITING","sponsor":"Yale University","startDate":"2022-05-11","conditions":"Deep Venous Thrombosis","enrollment":258},{"nctId":"NCT06868823","phase":"","title":"Prospective Observational Pilot Study of LMWH Versus UFH as ECMO Anticoagulation in Lung Transplantation","status":"RECRUITING","sponsor":"University Hospital, Motol","startDate":"2025-05-01","conditions":"Lung Transplantation, Extracorporeal Membrane Oxygenation (ECMO), Anticoagulants and Bleeding Disorders","enrollment":40},{"nctId":"NCT06114641","phase":"PHASE4","title":"Effectiveness & Safety of Ovine Enoxaparin Sodium to Originator Enoxaparin in Non-ST-Segment Elevation ACS Patients","status":"COMPLETED","sponsor":"PT Bio Farma","startDate":"2023-06-01","conditions":"Safety Issues, Effect of Drug","enrollment":220},{"nctId":"NCT06845423","phase":"PHASE4","title":"Prevention of Postpartum Venous Thromboembolism in Women at Intermediate Risk","status":"RECRUITING","sponsor":"University Hospital, Brest","startDate":"2025-05-16","conditions":"Venous Thromboembolism (VTE), Post Partum Women","enrollment":2400},{"nctId":"NCT05794165","phase":"PHASE2","title":"Antithrombin to Improve Thromboprophylaxis and Reduce the Incidence of Trauma-Related Venous Thromboembolism","status":"ENROLLING_BY_INVITATION","sponsor":"Bryan Cotton","startDate":"2023-09-27","conditions":"Trauma Injury, Thromboembolism, Venous Thromboembolism","enrollment":314},{"nctId":"NCT05484557","phase":"NA","title":"Prevention of Thromboembolism Using Apixaban vs Enoxaparin Following Spinal Cord Injury","status":"RECRUITING","sponsor":"Loewenstein Hospital","startDate":"2023-09-06","conditions":"Spinal Cord Injuries, Spinal Diseases","enrollment":60},{"nctId":"NCT06963320","phase":"PHASE2","title":"Phase II Clinical Study of H001 Capsule in the Prevention of Venous Thromboembolism After Total Knee Arthroplasty","status":"RECRUITING","sponsor":"Livzon Pharmaceutical Group Inc.","startDate":"2025-01-20","conditions":"Circulatory Disease","enrollment":320},{"nctId":"NCT04536272","phase":"PHASE3","title":"Reduced Anticoagulation Targets in ECLS (RATE)","status":"COMPLETED","sponsor":"University Medical Center Groningen","startDate":"2020-10-01","conditions":"Heart Failure, Respiratory Failure, Extracorporeal Membrane Oxygenation","enrollment":330},{"nctId":"NCT05735639","phase":"PHASE4","title":"THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE)","status":"RECRUITING","sponsor":"Imperial College London","startDate":"2024-01-22","conditions":"Venous Thromboembolism, Varicose Veins","enrollment":6660},{"nctId":"NCT06689241","phase":"NA","title":"Rivaroxaban Versus Enoxaparin for Prophylaxis of Venous Thromboembolism in Bariatric Surgery","status":"RECRUITING","sponsor":"Alexandria University","startDate":"2024-10-01","conditions":"Morbid Obesity, Bariatric Surgery Candidate","enrollment":162},{"nctId":"NCT03891524","phase":"PHASE2","title":"A Study of JNJ-70033093 (BMS-986177) Versus Subcutaneous Enoxaparin in Participants Undergoing Elective Total Knee Replacement Surgery","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2019-06-17","conditions":"Arthroplasty, Replacement, Knee","enrollment":1242},{"nctId":"NCT05895136","phase":"PHASE2","title":"A Novel COMBinATorial Therapy With Albumin and Enoxaparin in Patients With Decompensated Cirrhosis at High-risk of Poor Outcome (COMBAT Trial).","status":"RECRUITING","sponsor":"European Foundation for Study of Chronic Liver Failure","startDate":"2024-07-01","conditions":"Liver Cirrhosis, Decompensated Cirrhosis of Liver, Acute on Chronic Liver Failure (ACLF)","enrollment":90},{"nctId":"NCT06494878","phase":"PHASE3","title":"The PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity","status":"NOT_YET_RECRUITING","sponsor":"University of Calgary","startDate":"2025-04","conditions":"Venous Thromboembolism, Postpartum Period, Aspirin","enrollment":8805},{"nctId":"NCT05058924","phase":"NA","title":"Low Molecular Weight hEparin vs. Aspirin Post-partum","status":"COMPLETED","sponsor":"Mount Sinai Hospital, Canada","startDate":"2021-08-29","conditions":"Venous Thromboembolism","enrollment":30},{"nctId":"NCT02798471","phase":"PHASE3","title":"Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE)","status":"COMPLETED","sponsor":"Daiichi Sankyo","startDate":"2017-03-27","conditions":"Venous Thromboembolism (VTE), Pulmonary Embolism, Deep Vein Thrombosis (DVT)","enrollment":290},{"nctId":"NCT06010446","phase":"","title":"Intravenous Continuous LMWH Seems to Be Safe Alternative to UFH in VV ECMO Patients","status":"COMPLETED","sponsor":"University Hospital, Motol","startDate":"2019-05-15","conditions":"Refractory Respiratory Failure","enrollment":43},{"nctId":"NCT05245877","phase":"PHASE4","title":"Pre- Vs. Postoperative Thromboprophylaxis in Pancreatic Surgery","status":"RECRUITING","sponsor":"Helsinki University Central Hospital","startDate":"2022-08-17","conditions":"Pancreas Cancer, Pancreas Neoplasm, Surgery","enrollment":800},{"nctId":"NCT04731558","phase":"PHASE4","title":"Pre- Vs Postoperative Thromboprophylaxis for Liver Resection","status":"RECRUITING","sponsor":"Helsinki University Central Hospital","startDate":"2021-02-10","conditions":"Liver Cancer, Surgery, Thrombosis, Deep Vein","enrollment":1012},{"nctId":"NCT06818279","phase":"PHASE2, PHASE3","title":"Compare the Efficacy and Safety of Dabigatran and Enoxaparin in Patients With Portal Vein Thrombosis With Cirrhosis","status":"NOT_YET_RECRUITING","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2025-01-31","conditions":"Portal Vein Thrombosis, Liver Cirrhosis","enrollment":120},{"nctId":"NCT04362085","phase":"PHASE3","title":"Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care","status":"COMPLETED","sponsor":"Unity Health Toronto","startDate":"2020-05-11","conditions":"COVID-19","enrollment":465},{"nctId":"NCT06795698","phase":"PHASE2","title":"The Effect of Prophylactic Anticoagulation on Major Bleeding Events in Hospitalized Chronic Kidney Disease and Lower Limb Fracture Patients.","status":"COMPLETED","sponsor":"Hospital Civil de Guadalajara","startDate":"2019-03-01","conditions":"Fractures, Bone, CKD Stage 4, CKD Stage 3","enrollment":61},{"nctId":"NCT03532139","phase":"PHASE2","title":"Pilot Study of Rosuvastatin and Enoxaparin Thromboprophylaxis Following Ovarian Cancer Surgery (O-STAT Study)","status":"COMPLETED","sponsor":"Beth Israel Deaconess Medical Center","startDate":"2018-07-25","conditions":"Ovarian Cancer","enrollment":24},{"nctId":"NCT05752461","phase":"PHASE2","title":"SHR-2004 for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty","status":"COMPLETED","sponsor":"Beijing Suncadia Pharmaceuticals Co., Ltd","startDate":"2023-04-12","conditions":"Prevention of Venous Thromboembolism After Knee Arthroplasty","enrollment":353},{"nctId":"NCT04710732","phase":"PHASE4","title":"Individual Dose Adjustment of Low-molecular-weight-heparin by Thromodynamics Test.","status":"TERMINATED","sponsor":"Pirogov Russian National Research Medical University","startDate":"2021-03-01","conditions":"Venous Thromboembolism","enrollment":9},{"nctId":"NCT04505774","phase":"PHASE4","title":"Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 ACUTE","status":"COMPLETED","sponsor":"Matthew Neal MD","startDate":"2020-09-04","conditions":"Covid19","enrollment":3591},{"nctId":"NCT04367831","phase":"PHASE4","title":"Intermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19","status":"COMPLETED","sponsor":"Columbia University","startDate":"2020-05-02","conditions":"COVID-19, Venous Thromboses, Arterial Thrombosis","enrollment":94},{"nctId":"NCT04427098","phase":"PHASE2","title":"Enoxaparin in COVID-19 Moderate to Severe Hospitalized Patients","status":"COMPLETED","sponsor":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","startDate":"2020-05-22","conditions":"COVID-19","enrollment":301},{"nctId":"NCT05129800","phase":"","title":"Efficacy of Platelet-Rich Plasma Versus Mesotherapy in Androgenetic Alopecia: A Retrospective Study","status":"COMPLETED","sponsor":"Faculty Hospital Kralovske Vinohrady","startDate":"2011-01-01","conditions":"Androgenetic Alopecia, Hair Loss, Alopecia","enrollment":72},{"nctId":"NCT04979780","phase":"","title":"Observational Studies in Cancer Associated Thrombosis for Rivaroxaban - United States Cohort","status":"COMPLETED","sponsor":"Bayer","startDate":"2021-07-20","conditions":"Treatment of Venous Thromboembolism in Cancer Patients, Prophylaxis of Recurrent Venous Thromboembolism in Cancer Patients","enrollment":3708},{"nctId":"NCT05819112","phase":"","title":"A Comparison of Extended Versus Conventional Duration of Enoxaparin Prophylaxis (i.e., Preventive Treatment) for Venous Thromboembolism (VTE, i.e., Blood Clots in the Veins) and Bleeding Event Risk in a Population With Acute Medical Illness","status":"TERMINATED","sponsor":"Sanofi","startDate":"2023-04-25","conditions":"Venous Thromboembolism","enrollment":14799},{"nctId":"NCT01717573","phase":"NA","title":"Deferred Stent Trial in STEMI","status":"COMPLETED","sponsor":"NHS National Waiting Times Centre Board","startDate":"2012-03","conditions":"ST-Elevation Myocardial Infarction","enrollment":101},{"nctId":"NCT05819125","phase":"","title":"Comparison of the Risk of Venous Thromboembolism (i.e., Blood Clots in the Veins) and Bleeding Events in a Population of Obese Patients Receiving Higher-Dose or Extended-Duration Versus Conventional-Dose or Conventional-Duration of Prophylaxis (i.e., Preventive Treatment) With Enoxaparin","status":"TERMINATED","sponsor":"Sanofi","startDate":"2023-04-25","conditions":"Venous Thromboembolism","enrollment":21000},{"nctId":"NCT06442267","phase":"PHASE4","title":"Comparing Anticoagulation Strategies Using UFH, Argatroban and LMWH for ECMO Support","status":"RECRUITING","sponsor":"Medical University of Vienna","startDate":"2024-07-30","conditions":"Respiratory Insufficiency, Circulatory Failure, Thromboembolism","enrollment":90},{"nctId":"NCT06662240","phase":"NA","title":"Effect of Vibration Anesthesia on Pain, Ecchymosis and Comfort Level in Subcutaneous Heparin Injection","status":"COMPLETED","sponsor":"Ataturk University","startDate":"2024-03-15","conditions":"Pain, Ecchymosis, Comfort","enrollment":142},{"nctId":"NCT06662253","phase":"PHASE2, PHASE3","title":"Anti-Xa Guided Dosing of Low Molecular Weight Heparin for Prevention of Venous Thromboembolism Following Traumatic Injury: a Multicentre Pilot Randomized Trial","status":"NOT_YET_RECRUITING","sponsor":"Alexandre Tran","startDate":"2025-01","conditions":"Venous Thromboembolism (VTE), Trauma Related Injuries","enrollment":150},{"nctId":"NCT06635317","phase":"PHASE4","title":"Efficacy of Aspirin in Preventing Venous Thromboembolism","status":"COMPLETED","sponsor":"Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado","startDate":"2022-04-24","conditions":"Venous Thromboembolism (VTE), Total Joint Arthroplasty, Total Hip Arthroplasty (THA)","enrollment":60},{"nctId":"NCT06585319","phase":"PHASE2, PHASE3","title":"Pirfenidone LP or Collagen-polyvinylpyrrolidone in COVID-19","status":"COMPLETED","sponsor":"Materno-Perinatal Hospital of the State of Mexico","startDate":"2020-02-01","conditions":"COVID 19","enrollment":36},{"nctId":"NCT00251576","phase":"PHASE3","title":"Aggrastat to Zocor (AtoZ) - the Use of Two Approved Drugs to Treat Patients Who Have Experienced Chest Pain or a Heart Attack (0733-180)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"1999-11-01","conditions":"Acute Coronary Syndrome","enrollment":4497},{"nctId":"NCT01230658","phase":"","title":"Prophylactic Enoxaparin Dosing in Roux-en-Y Gastric Bypass Surgery Patients at St. Vincent Carmel","status":"COMPLETED","sponsor":"Ascension St. Vincent Carmel Hospital","startDate":"2010-01","conditions":"Obesity","enrollment":51},{"nctId":"NCT06531525","phase":"PHASE2","title":"Effect of Low Molecular Heparin on Pregnancy Outcome With Protein S Deficiency","status":"NOT_YET_RECRUITING","sponsor":"Peking University People's Hospital","startDate":"2024-08-01","conditions":"Pregnancy Related, Protein S Deficiency","enrollment":48},{"nctId":"NCT04508855","phase":"","title":"Management of Atrial Fibrillation in Patients With Cancer (MAFIC Study)","status":"WITHDRAWN","sponsor":"AHEPA University Hospital","startDate":"2020-08-01","conditions":"Cancer, Atrial Fibrillation","enrollment":""},{"nctId":"NCT04164693","phase":"NA","title":"Efficacy and Safety of Short-term Postoperative Anticoagulant Therapy to Prevente Thrombosis in Arterovenous Fistula","status":"COMPLETED","sponsor":"First Affiliated Hospital of Chongqing Medical University","startDate":"2019-01-01","conditions":"Thrombosis","enrollment":287},{"nctId":"NCT06416566","phase":"NA","title":"Low-Dose Enoxaparin in Psoriasis","status":"NOT_YET_RECRUITING","sponsor":"Zagazig University","startDate":"2024-05-15","conditions":"Psoriasis","enrollment":30},{"nctId":"NCT04483960","phase":"PHASE3","title":"Australasian COVID-19 Trial (ASCOT) ADAptive Platform Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Melbourne","startDate":"2020-07-28","conditions":"SARS-CoV-2 Infection (COVID-19)","enrollment":2200},{"nctId":"NCT02984384","phase":"PHASE3","title":"PREVENTion of Clot in Orthopaedic Trauma","status":"COMPLETED","sponsor":"Major Extremity Trauma Research Consortium","startDate":"2017-04-24","conditions":"Blood Clot, Trauma","enrollment":12424},{"nctId":"NCT06222216","phase":"NA","title":"The Effect of Chilled Needle on the Development of Pain and Ecchymosis in Subcutaneous Injection in Adults","status":"RECRUITING","sponsor":"TC Erciyes University","startDate":"2024-03-01","conditions":"Pain, Ecchymosis, A Randomized Controlled Trial","enrollment":60},{"nctId":"NCT05081375","phase":"PHASE4","title":"Pre-operative Enoxaparin in the Surgical Management of Multi-trauma Patients Undergoing Orthopedic Surgical Procedures","status":"TERMINATED","sponsor":"Valleywise Health","startDate":"2019-12-16","conditions":"Venous Thrombosis Deep (Limbs), Surgical Blood Loss","enrollment":6},{"nctId":"NCT06153394","phase":"PHASE3","title":"Prolonged Hypercoagulability Following Major Liver Resection for Malignancy","status":"NOT_YET_RECRUITING","sponsor":"Western University, Canada","startDate":"2024-06-01","conditions":"Hepatic Disease, Surgery-Complications, Hypercoagulability","enrollment":50},{"nctId":"NCT02342444","phase":"PHASE4","title":"Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD)","status":"RECRUITING","sponsor":"Oregon Health and Science University","startDate":"2014-02","conditions":"Trauma, Surgery, Deep Vein Thrombosis (DVT)","enrollment":606},{"nctId":"NCT06293287","phase":"PHASE2","title":"Enoxaparin for Preventing the Radical Artery Occlusion After the Transradial Access Hepatic Arterial Infusion Chemotherapy","status":"UNKNOWN","sponsor":"Zhongshan Hospital (Xiamen), Fudan University","startDate":"2024-01-31","conditions":"Radial Artery Occlusion","enrollment":156},{"nctId":"NCT06133803","phase":"PHASE4","title":"Lovenox With Aspirin in Thawed Blastocyst Transfer","status":"UNKNOWN","sponsor":"Fertility Center of Las Vegas","startDate":"2024-01-26","conditions":"Infertility, Female","enrollment":130},{"nctId":"NCT02604238","phase":"PHASE3","title":"Efficacy and Safety of Half Dose Alteplase Added to Heparine, in Patients With Moderate Pulmonary Embolism","status":"WITHDRAWN","sponsor":"Azienda U.S.L. 1 di Massa e Carrara","startDate":"2016-03","conditions":"Pulmonary Embolism","enrollment":""},{"nctId":"NCT05925140","phase":"PHASE1","title":"LUSZ Treatment Efficacy in Hospitalized COVID-19 Patients","status":"UNKNOWN","sponsor":"Lebanese University","startDate":"2020-03-28","conditions":"COVID-19, Hospitalized COVID-19 Patients","enrollment":1000},{"nctId":"NCT03339349","phase":"PHASE2","title":"Weight-Based Enoxaparin Dosing and Real-Time Dose Adjustment in Orthopaedic Trauma","status":"COMPLETED","sponsor":"University of Utah","startDate":"2017-11-15","conditions":"Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolus","enrollment":80}],"_emaApprovals":[],"_faersSignals":[{"count":3069,"reaction":"OFF LABEL USE"},{"count":2144,"reaction":"DYSPNOEA"},{"count":1992,"reaction":"PYREXIA"},{"count":1967,"reaction":"NAUSEA"},{"count":1882,"reaction":"DIARRHOEA"},{"count":1644,"reaction":"ANAEMIA"},{"count":1605,"reaction":"VOMITING"},{"count":1583,"reaction":"FATIGUE"},{"count":1556,"reaction":"PNEUMONIA"},{"count":1446,"reaction":"ACUTE KIDNEY INJURY"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"formularyStatus":[],"_approvalHistory":[{"date":"20240626","type":"SUPPL","sponsor":"GLAND","applicationNumber":"ANDA078990"},{"date":"20200319","type":"SUPPL","sponsor":"GLAND","applicationNumber":"ANDA078990"},{"date":"20220728","type":"SUPPL","sponsor":"GLAND","applicationNumber":"ANDA078990"},{"date":"20180928","type":"ORIG","sponsor":"GLAND","applicationNumber":"ANDA078990"},{"date":"20240626","type":"SUPPL","sponsor":"GLAND","applicationNumber":"ANDA078990"},{"date":"20230606","type":"ORIG","sponsor":"BE PHARMS","applicationNumber":"ANDA214646"},{"date":"20240614","type":"SUPPL","sponsor":"SANDOZ","applicationNumber":"ANDA077857"},{"date":"20200618","type":"SUPPL","sponsor":"SANDOZ","applicationNumber":"ANDA077857"},{"date":"20221209","type":"SUPPL","sponsor":"SANDOZ","applicationNumber":"ANDA077857"},{"date":"20100723","type":"ORIG","sponsor":"SANDOZ","applicationNumber":"ANDA077857"},{"date":"20110725","type":"SUPPL","sponsor":"SANDOZ","applicationNumber":"ANDA077857"},{"date":"20111031","type":"SUPPL","sponsor":"SANDOZ","applicationNumber":"ANDA077857"},{"date":"20131029","type":"SUPPL","sponsor":"SANDOZ","applicationNumber":"ANDA077857"},{"date":"20111122","type":"SUPPL","sponsor":"SANDOZ","applicationNumber":"ANDA077857"},{"date":"20151228","type":"SUPPL","sponsor":"SANDOZ","applicationNumber":"ANDA077857"},{"date":"20201030","type":"SUPPL","sponsor":"AMPHASTAR PHARM","applicationNumber":"ANDA076684"},{"date":"20141024","type":"SUPPL","sponsor":"AMPHASTAR PHARM","applicationNumber":"ANDA076684"},{"date":"20221115","type":"SUPPL","sponsor":"AMPHASTAR PHARM","applicationNumber":"ANDA076684"},{"date":"20110919","type":"ORIG","sponsor":"AMPHASTAR PHARM","applicationNumber":"ANDA076684"},{"date":"20120824","type":"SUPPL","sponsor":"AMPHASTAR PHARM","applicationNumber":"ANDA076684"},{"date":"20140623","type":"ORIG","sponsor":"ZYDUS PHARMS","applicationNumber":"ANDA076726"},{"date":"20200319","type":"SUPPL","sponsor":"ZYDUS PHARMS","applicationNumber":"ANDA076726"},{"date":"20220912","type":"SUPPL","sponsor":"ZYDUS PHARMS","applicationNumber":"ANDA076726"},{"date":"20160112","type":"SUPPL","sponsor":"ZYDUS PHARMS","applicationNumber":"ANDA076726"}],"developmentCodes":[],"ownershipHistory":[],"publicationCount":6035,"therapeuticAreas":["Cardiovascular"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Enoxaparin","genericName":"Enoxaparin","companyName":"Dana-Farber Cancer Institute","companyId":"dana-farber-cancer-institute","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":61,"withResults":16},"verificationStatus":"verified","dataCompleteness":{"mechanism":false,"indications":true,"safety":true,"trials":true,"score":3}}